Iron(II) sulfate release from drop-formed lipophilic matrices developed by special hot-melt technology

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 57, Issue 2, 2004, Pages 287-294

  Pallagi, E ^a   Vass, K ^a   Pintye Hodi K ^a   Kasa Jr P ^a   Falkay, G ^a   Eros, I ^a   Szabo Revesz P ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Gastric mucosa irritation; Hot melt technology; Iron(II) sulfate; Lipophilic matrix; Sustained release, in vitro dissolution, in vivo experiment

Indexed keywords

FERROUS SULFATE; PROPOLIS; TRISTEARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG FORMULATION; KINETICS; LIPOPHILICITY; MATHEMATICAL MODEL; NONHUMAN; RABBIT; STOMACH MUCOSA; SUSTAINED DRUG RELEASE;

EID: 1442286238     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2003.10.017     Document Type: Article

References (19)

1. Reynolds J.E.F. Martindale, The Extra Pharmacopoeia. 1996;747-748 Royal Pharmaceutical Society, London.
2. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 10th ed:2001;McGraw-Hill, Toronto. pp. 1494-1501.
3. Tapiero H., Gaté L., Tew D.K. Iron: deficiencies and requirements. Biomed. Pharmacother. 55:2001;324-332.
4. Meyer R. Gmelins Handbuch der Anorganischen Chemie, 59. Teil. B. 1936;394-420 Verlag Chemie GmbH, Berlin.
5. Salhab A.S., Zmeili S.M., Gharaibeh M.N., Elayan H.H., Sallam E., Al Deleq S. The bioequivalence study of Folifer-Z: a new formulation of sustained-release iron and zinc. Int. J. Pharm. 178:1999;171-181.
6. Dredán J., Antal I., Rácz I. Evaluation of mathematical models describing drug release from lipophilic matrices. Int. J. Pharm. 145:1996;61-64.
7. Dredán J., Zelkó R., Antal I., Bihari E., Rácz I. Effect of chemical properties on drug release from hydrophobic matrices. Int. J. Pharm. 160:1998;257-260.
8. Huang H.P., Mehta S.C., Radebaugh G.W., Fawzi M.B. Mechanism of drug release from an acrylic polymer-wax matrix tablet. J. Pharm. Sci. 83/6:1994;795-797.
9. Hamdani J., Moës A.J., Amighi K. Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm. 245:2002;167-177.
10. Barthelemy P., Laforêt J.P., Farah N., Joachim J. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. Eur. J. Pharm. Biopharm. 47:1999;87-90.
11. Schaefer T., Holm P., Kristensen H.G. Melt granulation in a laboratory scale high shear mixer. Drug Dev. Ind. Pharm. 16:1990;1249-1277.
12. Zhou F., Vervaet C., Remon J.P. Matrix pellets based on the combination of waxes starches and maltodextrins. Int. J. Pharm. 133:1996;155-160.
13. Voinovich D., Moneghini M., Perissutti B., Filipovic-Grcic J., Grabnar I. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int. J. Pharm. 203:2000;235-244.
14. Bülau H.C., Ulrich J. Parameters influencing the properties of drop-formed pastilles. Ulrich J. CGOM4. 1997;123-130 Shaker, Aachen.
15. H.C. Bülau, Zum Aufreinigungspotential pastillierter Schmelzen, Dissertation Universität Bremen, Verlag Schaker, Aachen, 1999, pp. 6-14.
16. Hassner T., Ulrich J., Pallagi E., Szabó-Révész P. Kugeln ohne Kanten, Einfluss der Oberflächeneigenschaften auf die Tropfenerstarrung von Schmelzen auf festen Oberflächen. Verfahrenstechnik. 35:2001;34-39.
17. Shargel L., Yu A. Applied Biopharmaceutics and Pharmacokinetics: Bioavailability and Bioequivalence. 1999;247-279 Appleton and Lange, Stamford, CT.
18. Qiu Y., Chindabaram N., Flood K. Design and evaluation of layered diffusional matrices for zero-order sustained-release. J. Controlled Release. 51:1998;123-130.
19. Muskó Z., Pintye-Hódi K., Gáspár R., Pintye J., Szabó-Révész P., Eros I., Falkay G. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets. Eur. J. Pharm. Biopharm. 51:2001;143-146.